Maurizio Ferrario Selected Research

Maurizio Ferrario Research Topics

Disease

23	Myocardial Infarction 12/2022 - 11/2002
17	Thrombosis (Thrombus) 12/2022 - 11/2002
16	ST Elevation Myocardial Infarction 01/2022 - 07/2007
14	Acute Coronary Syndrome 12/2022 - 11/2016
13	Hemorrhage 12/2022 - 11/2016
13	Stroke (Strokes) 12/2022 - 11/2016
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2005
6	Coronary Artery Disease (Coronary Atherosclerosis) 05/2022 - 01/2018
5	Death (Near-Death Experience) 05/2024 - 01/2019
5	Infarction (Infarctions) 01/2022 - 02/2011
4	Heart Failure 05/2024 - 10/2018
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 12/2014
2	Diabetes Mellitus 11/2023 - 03/2022
2	Hyperplasia 11/2023 - 04/2004
2	Pulmonary Hypertension 06/2022 - 10/2018
2	Atrial Fibrillation 03/2022 - 07/2018
2	Hypertension (High Blood Pressure) 03/2022 - 01/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 11/2002
2	Aortic Valve Stenosis (Aortic Stenosis) 10/2019 - 09/2018
2	Pathologic Constriction (Stenosis) 01/2005 - 11/2002
1	Mitral Valve Insufficiency (Mitral Regurgitation) 06/2022
1	MINOCA 05/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2022
1	Hypercholesterolemia 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Frailty 01/2020
1	Overweight 01/2020
1	Abdominal Aortic Aneurysm 10/2019
1	Aortic Aneurysm (Aneurysm, Aortic) 10/2019
1	Atherosclerosis 05/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 05/2019
1	Ischemic Stroke 07/2018
1	Atrial Flutter (Flutter, Atrial) 07/2018
1	Patent Foramen Ovale 07/2018
1	Chronic Renal Insufficiency 06/2018
1	Coronary Occlusion 10/2017
1	Non-ST Elevated Myocardial Infarction 11/2016
1	False Aneurysm (Pseudoaneurysm) 06/2013
1	Coronary Aneurysm (Aneurysm, Coronary) 12/2010
1	Blood Vessel Dissection 11/2002
1	Angina Pectoris 11/2002

Drug/Important Bio-Agent (IBA)

6	Clopidogrel (Plavix)FDA Link 12/2022 - 11/2016
6	TicagrelorIBA 01/2022 - 01/2018
5	Prasugrel Hydrochloride FDA Link 12/2022 - 11/2016
5	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 01/2019
4	Sirolimus (Rapamycin)FDA Link 11/2023 - 07/2007
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2018
4	Uric Acid (Urate)IBA 01/2021 - 05/2018
3	omega-Chloroacetophenone (Mace)IBA 05/2022 - 01/2005
2	Hemoglobins (Hemoglobin)IBA 12/2022 - 01/2020
2	CreatinineIBA 01/2022 - 10/2013
2	MetalsIBA 05/2019 - 07/2007
2	bivalirudin (Angiomax)FDA Link 01/2019 - 01/2018
2	Erythropoietin FDA Link 02/2011 - 08/2007
2	Abciximab (ReoPro)FDA Link 04/2008 - 07/2007
2	Tirofiban (Aggrastat)FDA Link 04/2008 - 07/2007
1	Everolimus FDA Link 11/2023
1	PolymersIBA 11/2023
1	Vasodilator Agents (Vasodilators)IBA 06/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	MB Form Creatine KinaseIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	acetylsalicylic acid lysinateIBA 01/2021
1	DiureticsIBA 01/2020
1	ElementsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	TroponinIBA 01/2018
1	AntithrombinsIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	HematinicsIBA 09/2014
1	Phosphotransferases (Kinase)IBA 10/2013
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2004

Therapy/Procedure

27	Percutaneous Coronary Intervention 11/2023 - 07/2007
26	Stents 11/2023 - 11/2002
10	Therapeutics 01/2022 - 04/2008
5	Patient Readmission 05/2024 - 11/2016
3	Drug-Eluting Stents 01/2022 - 05/2019
3	Transcatheter Aortic Valve Replacement 01/2021 - 09/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 01/2018
2	Ischemic Postconditioning 12/2014 - 10/2013
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 03/2022
1	Cardiac Resynchronization Therapy 03/2022
1	Investigational Therapies (Experimental Therapy) 11/2019
1	Thrombectomy 08/2019
1	Heart Transplantation (Grafting, Heart) 10/2018
1	Secondary Prevention 07/2018
1	Duration of Therapy 01/2018
1	Bioprosthesis 10/2017